In aggressive EC, the autotaxin–LPA axis contributes to tumor progression by fueling a pro-metastatic signaling loop: as LPA levels increase at the expense of LPC, LPA receptors on cancer cells drive processes like epithelial–mesenchymal transition, migration, and survival in the hostile circulation. Here, ENPP2 is linked to neoplasm.